Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

prostate-specific membrane antigen-targeted cisplatin/irinotecan-loaded nanoparticles

Based on

1 Patents
2014 Most recent source

Composition

1

PLGA-mPEG5K

Type Polymer
Formula
Role core
2

poly(lactide-co-glycolic acid)-polyethyleneglycol-S,S-2[3-][5-amino-1-carboxypentyl]-ureido]-pentanedioic acid

PLGA-mPEG5K-LIG
Type Polymer
Formula
Role layer
3

dual drug mixture

Type Complex Compound
Formula
Role loaded material

Properties

Applications

Area Application Source

Full content is available to subscribers only

To view content please choose from the following:

Characterization

Biological effects

Biological system Test details Source

Full content is available to subscribers only

To view content please choose from the following:

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • PLA-succinic acid-conjugated irinotecan
  • PLA-succinic acid-conjugated cisplatin
  • PLGA-mPEG5K
See all (4)
  1. bx5JpuLJdSKHQT0tuS7i3lwUP2h
Product

prostate-specific membrane antigen-targeted cisplatin/irinotecan-loaded nanoparticles

Method 2

Type: Physical formation
Source:
Starting materials
  • PLA-succinic acid-conjugated irinotecan
  • PLA-succinic acid-conjugated cisplatin
  • PLGA-mPEG5K
See all (4)
  1. PeY7cSEG7DFRoaARpI29GkIGjmg
Product

prostate-specific membrane antigen-targeted cisplatin/irinotecan-loaded nanoparticles

Method 3

Type: Physical formation
Source:
Starting materials
  • PLA-succinic acid-conjugated irinotecan
  • PLA-succinic acid-conjugated cisplatin
  • PLGA-mPEG5K
See all (4)
  1. O8TlZkpjV1hSo8BBIilakIUWUfv
Product

prostate-specific membrane antigen-targeted cisplatin/irinotecan-loaded nanoparticles

Method 4

Type: Physical formation
Source:
Starting materials
  • PLA-succinic acid-conjugated irinotecan
  • PLA-succinic acid-conjugated cisplatin
  • PLGA-mPEG5K
See all (4)
  1. uEFoztgodvUEheBbM8RzVs0utZa
Product

prostate-specific membrane antigen-targeted cisplatin/irinotecan-loaded nanoparticles

Method 5

Type: Physical formation
Source:
Starting materials
  • PLA-succinic acid-conjugated irinotecan
  • PLA-succinic acid-conjugated cisplatin
  • PLGA-mPEG5K
See all (4)
  1. rlHJ0jb0JBp7B4WxIcE2UdzZR99
Product

prostate-specific membrane antigen-targeted cisplatin/irinotecan-loaded nanoparticles

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial